EGF and breast carcinoma: We further investigated the underlying mechanisms of the activation of EGF signaling by PN-1 in breast cancer cells and demonstrated that PN-1 could prevent extracellular EGF proteolytic cleavage by HtrA1 through binding and blocking HtrA1.